Research article · 21 Jun 2021
Review articlePublished 2017
Critical Care Management and Newer Therapies for Tumour Lysis Syndrome
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cancer disorders are the one of the leading causes of death in most developed and developing countries. They constitute a diverse group of pathologies in which abnormal metabolism and life cycle lead to the profound derangement’s of host metabolism. With the recent advancement in the medical field, many cancer diseases are well controlled with early diagnosis and treatment. So, it is essential that clinicians must be aware the complications of cancer itself and its management. Tumour lysis syndrome (TLS) is an onco-metabolic emergency which occurs due to cancer cells targeted treatment (chemotherapy or radiotherapy) or from rapidly dividing cancer cells itself (spontaneous TLS). TLS was first described by Bedrna and Polcak in 1929 in a chronic leukemia patient treated with radiotherapy. It is characterized by a group of metabolic derangements characterised by hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia and uremia. The consequences are potentially lethal and may result in acute kidney failure, seizures, tetany and even sudden death. The scenario is further complicated in patient with underlying comorbid conditions and in patients at extremes of ages.
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2015
Identification of Children with Acute Lymphoblastic Leukemia at Low Risk for Tumor Lysis Syndrome
Opinion · 13 Sep 2022
Complications of Tumour Lysis Syndrome in the Body
Perspective · 4 Jul 2022
Association of Bruton's Tyrosine Kinase Inhibitor with Tumour Lysis Syndrome
Conference abstract · 27 Jun 2016
Tumour Lysis Syndrome: a rare acute presentation of advanced testicular cancer
More from this journal
The newest in Journal of Blood & Lymph.
Article · 19 Feb 2026
Perioperative Application of Point-of-Care Test for Blood Viscoelasticity
Commentary · 1 Jan 2026
Commentary on Prosthetic Valve Dysfunction Post-Bevacizumab: A TAVR Thrombosis
Commentary · 1 Jan 2026
The Interaction of Blood and Lymphatic Systems: Insights for Modern Hemato-Lymphatic Research
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Blood & Lymph
- SubjectHaematology
- BylineArticles whose byline prints “Uma Hariharan”
- BylineArticles whose byline prints “Vinodh Natarajan”

